Management of Pelvic Cystic Lesion with Mural Nodule in a 70-Year-Old Female with Renal Parenchymal Changes
The next step in management for this 70-year-old female should be an MRI of the pelvis and CA-125 testing as recommended in the ultrasound report, followed by gynecologic oncology consultation.
Assessment of Current Findings
Renal Findings
- Bilateral grade II renal parenchymal changes with:
- Increased parenchymal echotexture
- Partial obliteration of corticomedullary differentiation (CMD)
- Normal parenchymal thickness (14-15mm)
- No hydronephrosis or calculi
- These findings suggest chronic kidney disease that requires renal function testing (RFT) as recommended in the report
Pelvic Cystic Lesion
- 10.0 × 7.4 cm well-defined thick-walled cyst superior to the bladder
- Contains sedimented echogenic contents
- Presence of a 6.9 mm isoechoic mural nodule
- Location in the pelvis midline suggests possible ovarian origin, though the ovaries were not visualized separately
Diagnostic Workup
For the Pelvic Cystic Lesion
MRI of the pelvis (highest priority)
- Superior to ultrasound for characterizing complex cystic lesions 1
- Can better define the origin of the mass (ovarian vs. other pelvic structures)
- Can better characterize the mural nodule and internal components
CA-125 testing
- Important tumor marker for ovarian malignancy
- Elevated levels may suggest malignant potential
- Should be performed concurrently with MRI
Gynecologic oncology consultation
- Essential for evaluation of complex pelvic cystic lesions with suspicious features
- The presence of a mural nodule increases concern for malignancy
For the Renal Parenchymal Changes
- Renal function testing
Management Considerations
Pelvic Cystic Lesion
- The presence of a mural nodule in a thick-walled cyst raises significant concern for malignancy
- In a 70-year-old female, ovarian malignancy must be ruled out
- If MRI confirms complex features, surgical evaluation is likely necessary
- The differential diagnosis includes:
- Ovarian cystadenoma/cystadenocarcinoma
- Complex ovarian cyst
- Other pelvic cystic lesions (less likely)
Renal Parenchymal Changes
- Grade II renal parenchymal changes suggest moderate chronic kidney disease
- Renal function must be considered when planning any interventions for the pelvic mass
- Nephron-sparing approaches should be prioritized in any future interventions 2, 1
- Regular monitoring of renal function is necessary
Follow-up Plan
Short-term (1-2 weeks):
- Complete MRI of pelvis and CA-125 testing
- Renal function testing
- Gynecologic oncology consultation
Medium-term (based on initial results):
- If suspicious for malignancy: surgical planning with consideration of renal function
- If indeterminate: possible biopsy or short-interval follow-up imaging
- If benign features: surveillance imaging
Long-term:
- Regular monitoring of renal function
- Annual abdominal imaging to monitor both renal parenchymal changes and any residual or recurrent pelvic pathology
Pitfalls and Considerations
- Diagnostic pitfalls: Pelvic cysts can sometimes be misidentified between renal and ovarian origin 3
- Procedural considerations: Renal function must be considered when using contrast for MRI
- Age-related factors: At 70 years old, the risk of malignancy in complex cystic lesions is higher
- Comorbidity management: The bilateral renal parenchymal changes may impact treatment options and should be carefully evaluated
The presence of both a suspicious pelvic cystic lesion with a mural nodule and bilateral renal parenchymal changes requires careful coordination between gynecologic oncology and nephrology to ensure optimal management of both conditions.